Gayl Rogers Chrysler has over 30 years of leadership experience in strategic development and operational management of FDA regulatory-compliant businesses.  She started her medical career as a registered nurse working in blood apheresis.  Between 1982 and 2003 she worked for the North Central Blood Services of the American Red Cross. During her time at the Red Cross, she completed an MBA degree.  She increased the production capacity of the American Red Cross Apheresis Unit by 400% over a 3 year period, becoming one of the largest Apheresis Units in the U.S.  She also has worked in organ and tissue donation and has been an associate editor of the Journal of Transplant Coordination since 1991.  She created and implemented innovations to increase consented cadaver tissue donors by 300% over a one year period.  Chrysler helped create the Unrelated Bone Marrow Donor Program for the American Red Cross, a prototype for the National Marrow Donor Program.  Gayl Chrysler is best known in cord blood circles for her work as the National Director of Operations of the Cord Blood Program at the American Red Cross.  She transformed the American Red Cross Cord Blood Bank into a profitable financial operation and the fourth largest Cord Blood Bank in the U.S. after only 5 years of operations.  Chrysler joined BioE in 2006 as vice president of cellular technologies and clinical affairs.  There she was responsible for commercialization and global marketing of BioE's PrepaCyte cell separation technology. In 2012 Chrysler became the first Director of Biobanking Sales Strategy and Alliances for STEMCELL Technologies in Vancouver. Since July 2015 Chrysler heads up biomedical business development for Innovative Blood Resources.  

Stem cell